FDA Grants EUA to Applied DNA Linea™ COVID-19 Assay Kit

May 12, 2021

Read More

APDN Receives CLIA Certification, Enabling High Throughput COVID-19 Testing

May 11, 2021

Read More

APDN Schedules FY’21 Q2 Financial Results Conference Call/Webcast

May 7, 2021

Read More

Applied DNA and Evvivax Announce that LinearDNA™ COVID-19 Vaccine Candidate Booster Yields 5-Fold Average Increase in Neutralizing Antibody Titers in Domestic Felines

May 6, 2021

Read More

Applied DNA Signs New Contract with U.S. Defense Logistics Agency

May 5, 2021

Read More

APDN Secures Amendment to MSA and 4th Blanket Purchase Order

April 26, 2021

Read More

APDN Provides Preliminary Estimated FQ2’21 Revenue Range and Business Update

April 21, 2021

Read More

APDN, Evvivax Announce Positive Preliminary Results of Phase I Clinical Trial

April 12, 2021

Read More

Applied DNA CEO Discusses Relevance of DNA-based Cotton Traceability as Enabler of Ethical and Responsible Textile Manufacturing on BBC Business Daily

April 8, 2021

Read More